Hub : Traits :

Hypertension (Self-reported)

1099 significantly associated models · 334 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 752566 2061969 1 1 3.7e-07 3.6e-06 3.7e-03 61 RP4-758J18.10
2 1 5829039 7221458 1 1 1.9e-07 1.2e-06 1.5e-02 75 TNFRSF25
3 1 7715776 9571422 2 1 7.9e-09 1.9e-08 2.3e-01 96 RP5-1115A15.1
4 1 10435170 12769239 9 9 2.7e-21 3.7e-30 0.0e+00 -1650 AGTRAP CLCN6 DRAXIN MFN2 NPPA-AS1 RP4-635E18.7
5 1 26428864 28406173 3 2 3.0e-08 2.9e-07 1.8e-01 93 CD164L2 PIGV
6 1 88621347 90053563 1 1 1.0e-09 8.8e-10 8.9e-02 92 GTF2B
7 1 112312154 113941737 4 2 2.2e-12 8.5e-22 1.9e-15 31 WNT2B
8 1 230142626 231548480 1 1 1.5e-12 2.4e-12 1.0e+00 100 AGT
9 2 24021231 26068509 3 2 6.6e-12 2.7e-10 2.0e-02 86 EFR3B NCOA1
10 2 26223547 27689899 2 2 5.4e-09 1.4e-34 3.0e-25 28 KCNK3 SLC35F6
11 2 36778887 38298877 2 1 3.6e-10 1.4e-09 1.0e+00 100 PRKD3
12 2 218622292 220128895 1 1 6.1e-08 6.4e-05 6.6e-01 99 USP37
13 3 10617048 12457119 2 1 9.5e-09 9.2e-11 2.6e-03 78 ATG7
14 3 19382787 20893060 1 1 3.5e-07 7.9e-08 5.9e-02 88 KAT2B
15 3 26563909 28211713 2 1 2.4e-20 9.7e-18 6.1e-05 78 SLC4A7
16 3 38812165 40267321 1 1 2.4e-07 7.2e-06 2.2e-03 54 MOBP
17 3 47204518 49365269 8 1 4.5e-12 2.9e-12 1.0e+00 100 FCF1P2
18 3 55955214 57412804 1 1 5.3e-08 1.0e-06 5.0e-02 84 C3orf63
19 3 137189600 138819532 2 1 7.7e-08 4.1e-08 2.2e-01 95 MRAS
20 3 157125828 159106064 3 1 2.9e-09 7.5e-08 3.1e-01 96 RP11-538P18.2
21 3 183204923 184607480 1 1 1.8e-07 6.5e-07 4.2e-01 97 ABCF3
22 4 17104059 18507692 1 1 6.4e-09 1.8e-08 2.6e-02 84 DCAF16
23 4 25880334 27452482 1 1 2.9e-09 2.8e-12 1.2e-05 61 TBC1D19
24 4 37915462 39361551 2 1 4.0e-09 1.9e-08 2.1e-04 56 FLJ13197
25 4 80407869 82578407 3 2 4.8e-20 1.1e-67 2.4e-44 35 C4orf22 PRDM8
26 4 102852939 104627833 6 1 2.3e-11 1.7e-10 8.8e-01 100 CISD2
27 4 110590479 112179424 1 1 7.5e-08 7.3e-13 1.1e-08 37 ENPEP
28 4 155960819 157354250 1 1 1.0e-07 3.0e-12 1.4e-11 6 RP11-588K22.2
29 5 60903201 62529686 1 1 2.7e-07 5.9e-07 6.3e-01 99 KIF2A
30 5 95383587 96773894 1 1 3.3e-07 1.9e-06 8.0e-02 86 CTC-506B8.1
31 5 113910679 115330276 1 1 8.1e-10 2.1e-12 1.1e-04 70 CCDC112
32 5 126596610 128116643 1 1 2.0e-08 1.4e-14 7.7e-08 51 CTC-228N24.3
33 5 130830617 132425049 7 1 2.8e-08 1.2e-07 2.7e-01 96 PDLIM4
34 5 147516165 148894875 1 1 6.1e-08 3.3e-08 6.2e-05 47 ADRB2
35 5 176043333 177591495 2 1 8.4e-08 1.1e-06 1.0e+00 100 DBN1
36 6 14551209 16209635 1 1 9.3e-08 5.2e-07 1.3e-02 76 JARID2
37 6 42586058 44034691 1 1 2.3e-09 1.7e-12 1.7e-04 72 ZNF318
38 6 78880271 80486611 2 1 1.3e-08 1.6e-08 1.8e-01 94 PHIP
39 6 96275538 97699026 1 1 1.7e-08 5.1e-09 8.3e-02 91 UFL1
40 6 117187910 118613435 1 1 1.9e-07 9.1e-10 8.8e-10 0 GOPC
41 6 125970401 128536730 3 3 9.2e-12 1.7e-30 1.9e-13 59 C6orf174 CENPW PRELID1P1
42 7 1854263 3264728 1 1 8.2e-11 1.8e-10 1.0e+00 100 LFNG
43 7 6502367 7988091 1 1 2.1e-14 1.0e-10 1.0e-01 94 C1GALT1
44 7 73425238 75714883 7 2 4.3e-09 9.0e-09 3.4e-01 97 PMS2P5 STAG3L1
45 7 76506844 77966572 1 1 9.1e-08 1.3e-06 1.4e-01 91 PTPN12
46 7 99081730 100516003 2 1 4.1e-08 3.6e-07 6.5e-01 99 PVRIG
47 7 129342404 130779678 1 1 9.4e-09 1.1e-12 6.4e-12 7 CEP41
48 7 132241297 134834499 2 2 1.1e-08 2.8e-09 4.5e-01 98 AKR1B1 EXOC4
49 8 8092025 13120332 27 2 1.3e-14 4.2e-13 7.1e-04 78 MSRA NEIL2
50 8 29996824 31433801 1 1 2.0e-08 9.4e-09 1.7e-01 94 TEX15
51 8 82017372 83452091 1 1 3.3e-07 2.1e-08 8.7e-03 78 SNX16
52 8 90238179 91709053 2 1 2.7e-07 3.6e-08 2.8e-02 84 OSGIN2
53 8 95213858 96825195 1 1 1.1e-08 8.9e-08 4.7e-01 98 NDUFAF6
54 8 102002608 103832256 2 1 4.2e-09 1.3e-09 6.2e-04 68 KB-1107E3.1
55 8 143110435 144515639 1 1 3.2e-07 6.5e-08 5.2e-03 73 THEM6
56 9 35208145 36597142 1 1 1.2e-08 7.0e-09 2.8e-03 74 HRCT1
57 10 18221643 19601824 2 1 1.6e-08 6.3e-17 6.4e-13 26 NSUN6
58 10 59577377 61286904 1 1 7.3e-09 3.9e-09 1.0e+00 100 BICC1
59 10 63856856 65606229 3 1 1.1e-11 3.6e-10 2.5e-02 87 NRBF2
60 10 87495534 88960852 2 1 7.4e-08 4.9e-08 3.1e-02 84 LDB3
61 10 95379543 96988739 2 2 1.4e-10 2.9e-13 3.5e-03 84 NOC3L TBC1D12
62 10 103313599 105850787 8 1 7.2e-14 4.5e-15 1.8e-02 91 NT5C2
63 10 115244596 116689519 1 1 1.5e-07 6.3e-19 1.4e-14 25 TDRD1
64 10 133325470 135295396 2 2 1.7e-07 7.0e-08 7.1e-01 100 INPP5A STK32C
65 11 1213806 2705175 3 2 1.2e-19 2.0e-23 1.7e-04 86 TNNT3
66 11 9003306 10471931 1 1 1.3e-07 5.1e-10 6.8e-08 25 SWAP70
67 11 42881882 44596817 2 1 6.1e-08 3.8e-10 6.5e-04 70 HSD17B12
68 11 46010847 48783497 19 1 6.3e-24 1.2e-19 8.2e-07 70 ACP2
69 11 63305184 64701030 1 1 2.0e-08 7.5e-08 1.0e+00 100 VEGFB
70 11 64721908 66333072 2 2 7.6e-10 3.0e-13 2.2e-02 90 CTSW SIPA1
71 11 99859184 101559718 2 1 2.7e-36 2.5e-35 8.5e-02 98 TMEM133
72 11 106485489 108027561 2 1 6.4e-10 7.6e-10 2.6e-03 76 CWF19L2
73 11 110721187 112491227 5 1 2.9e-11 3.0e-11 1.0e+00 100 SIK2
74 12 47737273 49444545 3 1 2.9e-08 1.1e-08 8.7e-08 12 ZNF641
75 12 49673158 51256065 4 2 4.5e-11 3.7e-12 3.3e-09 28 AQP5 CERS5
76 12 55694116 57082058 1 1 3.3e-07 2.0e-05 3.0e-01 94 SUOX
77 12 69057879 70476863 1 1 1.2e-08 1.8e-06 8.2e-01 100 YEATS4
78 12 89116708 90799212 2 1 9.5e-17 3.9e-25 4.9e-15 43 ATP2B1
79 12 109591369 111015121 1 1 1.5e-08 4.5e-08 1.8e-01 94 GLTP
80 12 111102574 113517494 14 1 3.0e-19 1.6e-27 2.9e-11 62 SH2B3
81 12 121146219 123131824 3 3 2.3e-14 5.6e-14 1.0e+00 100 KDM2B RNF34 WDR66
82 13 29641514 31108727 1 1 8.5e-10 1.4e-10 3.1e-02 89 UBL3
83 15 40360741 42749023 8 1 1.3e-11 9.8e-12 1.1e-01 94 CHP1
84 15 73933444 76108550 12 8 9.6e-22 2.7e-21 1.0e+00 100 ARID3B COX5A CSK CYP11A1 MPI RPP25 ULK3
85 15 80377452 81936479 1 1 5.3e-14 1.7e-14 7.9e-02 95 KIAA1199
86 15 90712555 92187978 3 1 6.9e-33 1.5e-28 8.4e-01 100 FES
87 16 3025993 5441125 3 3 8.2e-10 8.9e-09 6.5e-06 38 AC006111.1 MGRN1
88 16 29711343 31892919 12 1 4.5e-10 5.9e-09 4.4e-01 98 KAT8
89 16 69323837 71292172 8 1 8.7e-09 1.6e-07 1.0e+00 100 AARS
90 16 74778006 76197034 1 1 2.5e-07 6.2e-06 2.7e-01 94 TMEM170A
91 16 89013848 90172696 9 1 9.5e-14 3.8e-14 4.2e-02 93 CDK10
92 17 1517914 2918626 1 1 3.0e-07 4.5e-08 1.8e-03 67 SRR
93 17 3208350 4766937 2 1 6.6e-10 3.7e-09 3.8e-01 98 RP11-810M2.2
94 17 6493198 8484683 8 3 1.7e-11 6.3e-13 5.8e-01 99 LSMD1 SENP3 SLC2A4
95 17 44788310 45597098 1 1 1.9e-07 1.4e-11 2.1e-11 2 WNT3
96 17 45921906 47718188 6 2 1.1e-10 2.7e-14 2.5e-12 15 HOXB2 RP11-463M16.4
97 17 60858059 62279811 1 1 5.0e-15 9.4e-16 1.0e+00 100 ACE
98 17 73175294 74629867 4 1 1.2e-08 8.5e-09 2.6e-01 96 FBF1
99 17 78665405 80023050 1 1 2.1e-07 8.0e-06 1.9e-04 30 RP11-1055B8.4
100 19 1163934 2560423 2 2 7.4e-10 4.3e-09 1.0e+00 100 CTB-31O20.6 KLF16
101 19 16045294 18007950 4 3 1.7e-12 5.8e-14 1.0e+00 100 CTC-429P9.1 CTD-3032J10.3 MYO9B
102 19 48464978 49935001 4 1 1.2e-08 1.5e-08 1.0e+00 100 RASIP1
103 20 7419920 9648826 1 1 4.9e-10 9.1e-19 3.2e-10 50 PLCB1
104 20 29927166 31469577 2 2 1.1e-08 7.6e-07 4.2e-05 31 C20orf160 TSPY26P
105 20 56858751 58262841 2 1 8.3e-10 2.5e-34 4.8e-28 19 NELFCD
106 20 61522825 62912463 7 4 2.2e-12 4.6e-12 1.0e+00 100 LIME1 TCEA2 TPD52L2 ZBTB46
107 21 44512286 45879403 1 1 2.3e-07 5.2e-08 1.7e-07 8 PDXK
108 22 28792887 30261219 1 1 4.4e-09 1.2e-08 8.4e-05 52 KREMEN1

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Alzheimer’s Disease (including proxy) 1.70 4 2 6.1 0.99 7.0e-03 ACE KAT8 PRKD3 PVRIG
Crohns Disease (2017) 1.39 3 2 6.1 0.00 1.0e+00 PDLIM4 PMS2P5 RASIP1
Irritable Bowel Disease (IBD) 1.31 2 1 3.0 0.00 1.0e+00 PDLIM4 PMS2P5
Major Depression (MDD) 1.13 1 0 0.0 0.00 1.0e+00 FES
Reaction Time 1.20 1 1 3.0 0.00 1.0e+00 SH2B3
Verbal and Numeric Reasoning (VNR) 1.11 3 1 3.0 0.00 1.0e+00 DCAF16 SUOX TEX15
Breast Cancer 2.16 8 3 9.1 -0.25 5.4e-01 CSK FES PDLIM4 PMS2P5 RP11-1055B8.4 SIK2 SLC4A7 TNNT3
Ovarian Cancer 1.16 2 0 0.0 0.00 1.0e+00 HOXB2 WNT3
Prostate Cancer 1.43 1 0 0.0 0.00 1.0e+00 TNNT3
Body Mass Index (BMI) (2010) 1.51 1 0 0.0 0.00 1.0e+00 STAG3L1
Coronary Artery Disease (CAD) 2.01 3 2 6.1 0.00 1.0e+00 MRAS RP11-463M16.4 SH2B3
Crohns Disease (2012) 1.28 2 1 3.0 0.00 1.0e+00 PDLIM4 RASIP1
Fasting Glucose 1.57 1 1 3.0 0.00 1.0e+00 ACP2
HDL Cholesterol 1.34 3 1 3.0 0.00 1.0e+00 ACP2 CTSW PIGV
LDL Cholesterol 1.50 3 1 3.0 0.00 1.0e+00 PIGV RASIP1 SH2B3
Neuroticism 1.29 2 0 0.0 0.00 1.0e+00 MSRA NEIL2
Primary Biliary Cirrhosis 1.25 2 1 3.0 0.00 1.0e+00 CISD2 SH2B3
Rheumatoid Arthritis 1.08 2 0 0.0 0.00 1.0e+00 SH2B3 SUOX
Schizophrenia 1.56 4 2 6.1 -0.26 7.4e-01 CERS5 FES NT5C2 RP5-1115A15.1
Triglycerides 1.41 3 0 0.0 0.00 1.0e+00 KAT8 NEIL2 NRBF2
Type 2 Diabetes (T2D) 1.70 2 0 0.0 0.00 1.0e+00 HOXB2 HSD17B12
Blood Eosinophil Count 3.42 20 15 45.5 -0.61 3.9e-03 ADRB2 CD164L2 CERS5 FBF1 FLJ13197 GLTP KAT8 NDUFAF6 PDLIM4 PDXK PIGV RP5-1115A15.1 SH2B3 SIK2 SIPA1 SLC2A4 STK32C SUOX TSPY26P WNT3
Blood Platelet Count 2.30 43 30 90.9 0.09 5.6e-01 ABCF3 AGTRAP C20orf160 C3orf63 CDK10 CERS5 CLCN6 COX5A CSK CTC-506B8.1 CTSW DCAF16 FBF1 FLJ13197 GTF2B KIF2A KREMEN1 LFNG LIME1 MFN2 MGRN1 MPI MYO9B NELFCD NRBF2 PDLIM4 PHIP PIGV RASIP1 RP11-463M16.4 RPP25 SH2B3 SIK2 SLC4A7 SNX16 SWAP70 TBC1D12 TMEM170A TNNT3 USP37 WNT2B ZNF318 ZNF641
Blood Red Count 1.84 38 24 72.7 -0.30 5.5e-02 ARID3B C20orf160 C3orf63 C4orf22 C6orf174 CDK10 CENPW CLCN6 COX5A CSK CYP11A1 FBF1 FLJ13197 GTF2B INPP5A KAT8 LSMD1 MGRN1 MPI NCOA1 NDUFAF6 NELFCD NPPA-AS1 NT5C2 PDXK PVRIG RPP25 SH2B3 SLC35F6 SUOX TBC1D12 TDRD1 TSPY26P ULK3 USP37 VEGFB WNT3 ZNF641
Blood White Count 1.95 26 14 42.4 -0.48 1.4e-02 ADRB2 CDK10 CERS5 CTC-429P9.1 DCAF16 EFR3B FBF1 FES FLJ13197 GTF2B KAT2B KB-1107E3.1 KCNK3 LSMD1 MGRN1 MOBP NRBF2 NT5C2 PDLIM4 RP5-1115A15.1 SH2B3 SRR TBC1D12 TEX15 TMEM133 VEGFB
Heel T-Score 2.27 31 25 75.8 0.10 5.9e-01 ACP2 ATG7 BICC1 C20orf160 C6orf174 CTSW DCAF16 FLJ13197 GTF2B INPP5A KAT8 KREMEN1 LFNG LSMD1 NCOA1 NELFCD NT5C2 PMS2P5 RP11-810M2.2 RP4-635E18.7 RP5-1115A15.1 SENP3 SIPA1 SLC2A4 STK32C TMEM133 TNFRSF25 WNT2B WNT3 ZNF318 ZNF641
BMI 2.20 39 23 69.7 -0.62 2.6e-05 AARS AC006111.1 C20orf160 C4orf22 CEP41 CHP1 CISD2 COX5A CTB-31O20.6 CTC-506B8.1 CTSW FBF1 FLJ13197 HSD17B12 KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MRAS NRBF2 NT5C2 PMS2P5 RNF34 RP11-463M16.4 RP11-538P18.2 RP4-758J18.10 RP5-1115A15.1 RPP25 SRR STAG3L1 SUOX TDRD1 TEX15 TNFRSF25 TSPY26P USP37 ZNF318
Height 1.64 51 39 118.2 0.39 4.5e-03 AC006111.1 ACE ACP2 BICC1 C20orf160 CCDC112 CENPW CERS5 CHP1 CTC-228N24.3 CTSW CYP11A1 DBN1 DCAF16 EFR3B FES GOPC GTF2B HOXB2 HRCT1 MGRN1 NCOA1 NT5C2 PDLIM4 PIGV PRELID1P1 PTPN12 RASIP1 RP11-1055B8.4 RP11-463M16.4 RP11-538P18.2 RP11-810M2.2 RP4-635E18.7 RP5-1115A15.1 SENP3 SH2B3 SLC35F6 SLC4A7 STAG3L1 TBC1D12 THEM6 TMEM133 TMEM170A TNNT3 USP37 WDR66 WNT2B WNT3 YEATS4 ZNF318 ZNF641
Waist Hip Ratio (WHR) 2.01 22 15 45.5 -0.45 3.7e-02 C6orf174 CEP41 CTD-3032J10.3 CTSW CYP11A1 DBN1 GTF2B KREMEN1 MRAS MYO9B NCOA1 PRELID1P1 PTPN12 RASIP1 SIK2 SIPA1 SWAP70 TBC1D19 TCEA2 VEGFB WNT3 ZNF318
Systolic Blood Pressure 11.98 120 101 306.1 -0.96 1.1e-73 AARS ABCF3 AC006111.1 ACE ACP2 ADRB2 AGT AGTRAP AKR1B1 AQP5 ARID3B ATG7 ATP2B1 BICC1 C1GALT1 C20orf160 C3orf63 C4orf22 C6orf174 CCDC112 CD164L2 CENPW CERS5 CHP1 CLCN6 COX5A CSK CTB-31O20.6 CTC-228N24.3 CTC-429P9.1 CTD-3032J10.3 CTSW CWF19L2 CYP11A1 DCAF16 DRAXIN EFR3B ENPEP FBF1 FCF1P2 FES FLJ13197 GLTP GOPC GTF2B HOXB2 HRCT1 KAT2B KB-1107E3.1 KDM2B KIAA1199 KIF2A KLF16 KREMEN1 LDB3 LFNG LIME1 LSMD1 MFN2 MGRN1 MPI MRAS MYO9B NCOA1 NDUFAF6 NEIL2 NELFCD NOC3L NPPA-AS1 NRBF2 NSUN6 NT5C2 PDXK PHIP PIGV PLCB1 PMS2P5 PRDM8 PRELID1P1 PRKD3 PTPN12 RASIP1 RNF34 RP11-1055B8.4 RP11-463M16.4 RP11-538P18.2 RP11-588K22.2 RP4-635E18.7 RP4-758J18.10 RP5-1115A15.1 RPP25 SENP3 SH2B3 SIK2 SIPA1 SLC2A4 SLC4A7 SNX16 SRR STAG3L1 SWAP70 TBC1D12 TBC1D19 TCEA2 THEM6 TMEM133 TMEM170A TNFRSF25 TNNT3 TPD52L2 UBL3 UFL1 ULK3 VEGFB WDR66 WNT2B WNT3 ZBTB46 ZNF318 ZNF641
Smoking Status 1.24 7 0 0.0 -0.31 5.0e-01 CTSW FES KIAA1199 RP11-463M16.4 RP5-1115A15.1 SRR SUOX
Allergy or Eczema 2.06 12 4 12.1 -0.09 7.8e-01 CHP1 CLCN6 LIME1 NRBF2 PDLIM4 PDXK RNF34 RP5-1115A15.1 SIK2 SRR SUOX ULK3
Cardiovascular Disease 12.31 136 112 339.4 -0.99 8.2e-122 AARS ABCF3 AC006111.1 ACE ACP2 ADRB2 AGT AGTRAP AKR1B1 AQP5 ARID3B ATG7 ATP2B1 BICC1 C1GALT1 C20orf160 C4orf22 C6orf174 CCDC112 CD164L2 CDK10 CENPW CEP41 CERS5 CHP1 CISD2 CLCN6 COX5A CSK CTB-31O20.6 CTC-228N24.3 CTC-429P9.1 CTC-506B8.1 CTD-3032J10.3 CTSW CWF19L2 CYP11A1 DBN1 DCAF16 DRAXIN EFR3B ENPEP EXOC4 FBF1 FCF1P2 FES FLJ13197 GLTP GOPC GTF2B HOXB2 HRCT1 HSD17B12 JARID2 KAT2B KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KIF2A KLF16 KREMEN1 LDB3 LFNG LIME1 LSMD1 MFN2 MGRN1 MOBP MPI MRAS MYO9B NCOA1 NDUFAF6 NELFCD NOC3L NPPA-AS1 NRBF2 NSUN6 NT5C2 OSGIN2 PDXK PHIP PIGV PLCB1 PMS2P5 PRDM8 PRELID1P1 PTPN12 PVRIG RASIP1 RNF34 RP11-1055B8.4 RP11-463M16.4 RP11-538P18.2 RP11-588K22.2 RP11-810M2.2 RP4-635E18.7 RP4-758J18.10 RP5-1115A15.1 RPP25 SENP3 SH2B3 SIK2 SIPA1 SLC2A4 SLC35F6 SLC4A7 SNX16 STAG3L1 SUOX SWAP70 TBC1D12 TBC1D19 TCEA2 TDRD1 TEX15 THEM6 TMEM133 TMEM170A TNFRSF25 TNNT3 TPD52L2 TSPY26P UBL3 UFL1 ULK3 USP37 VEGFB WDR66 WNT2B YEATS4 ZBTB46 ZNF318 ZNF641
Hypothyroidism (self reported) 1.98 4 4 12.1 -0.90 1.0e-01 RASIP1 RP5-1115A15.1 SH2B3 SUOX
Respiratory disease 1.69 6 3 9.1 -0.08 8.8e-01 CHP1 FBF1 PDLIM4 RP5-1115A15.1 SIK2 SUOX
Type 2 Diabetes (T2D) 2.06 9 3 9.1 -0.71 3.3e-02 ACE CTSW MRAS NDUFAF6 PMS2P5 PRELID1P1 SH2B3 VEGFB ZBTB46
Lung FEV1/FVC ratio 1.89 22 14 42.4 0.35 1.1e-01 ATG7 ATP2B1 C1GALT1 C3orf63 CENPW CEP41 CTB-31O20.6 GOPC INPP5A KB-1107E3.1 NRBF2 PDLIM4 PVRIG RASIP1 RP11-810M2.2 RP5-1115A15.1 SUOX TMEM133 TMEM170A TNFRSF25 TSPY26P WNT3
Lung FVC 1.55 19 9 27.3 0.09 7.2e-01 C1GALT1 CHP1 CTC-228N24.3 CTD-3032J10.3 DCAF16 HOXB2 HSD17B12 KAT8 NCOA1 NRBF2 NT5C2 PDLIM4 RP11-538P18.2 SH2B3 SUOX TNFRSF25 WNT2B WNT3 ZBTB46
Neuroticism 1.08 3 3 9.1 0.00 1.0e+00 NT5C2 RP5-1115A15.1 WNT3
Chronotype (morning person) 1.15 2 0 0.0 0.00 1.0e+00 RP11-810M2.2 RP5-1115A15.1
Hair Pigment 3.36 15 10 30.3 -0.23 4.0e-01 ACP2 ATP2B1 C20orf160 C4orf22 CDK10 CTSW FES FLJ13197 HOXB2 PIGV RP5-1115A15.1 SH2B3 SIPA1 TSPY26P WNT3
Tanning 3.72 6 3 9.1 0.62 1.9e-01 CDK10 DBN1 NRBF2 SH2B3 TSPY26P ULK3
Hand grip strength (left) 1.42 5 2 6.1 -0.86 6.3e-02 DCAF16 FES HOXB2 MGRN1 PDLIM4
Number of treatments/medications taken 3.87 9 4 12.1 0.97 1.3e-05 ACE CHP1 CISD2 DCAF16 FLJ13197 KIAA1199 SH2B3 TMEM133 YEATS4
Average weekly spirits intake 1.21 1 0 0.0 0.00 1.0e+00 RASIP1
Sensitivity / hurt feelings 1.07 2 1 3.0 0.00 1.0e+00 FES WNT3
Frequency of depressed mood in last 2 weeks 0.98 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Hearing difficulty/problems: Yes 1.07 1 1 3.0 0.00 1.0e+00 ZNF318
Relative age of first facial hair 1.32 5 3 9.1 -0.71 1.8e-01 AARS ATG7 C4orf22 SIPA1 WNT3
Systolic blood pressure, automated reading 8.70 79 53 160.6 0.98 5.5e-59 AARS AC006111.1 ACP2 ADRB2 AGT AGTRAP AQP5 ATG7 ATP2B1 BICC1 C3orf63 C4orf22 C6orf174 CERS5 CHP1 CLCN6 COX5A CSK CTB-31O20.6 CTC-228N24.3 CTSW CWF19L2 DCAF16 DRAXIN FCF1P2 FES FLJ13197 GLTP GOPC GTF2B HOXB2 INPP5A KIAA1199 KIF2A KLF16 LFNG LIME1 MFN2 MGRN1 MPI MSRA MYO9B NCOA1 NEIL2 NELFCD NOC3L NPPA-AS1 NRBF2 NSUN6 NT5C2 PHIP PIGV PMS2P5 PRELID1P1 PRKD3 RASIP1 RP11-538P18.2 RP11-588K22.2 RP4-635E18.7 RP5-1115A15.1 RPP25 SENP3 SH2B3 SLC2A4 SLC4A7 SRR STAG3L1 SWAP70 TBC1D12 TCEA2 TMEM133 TMEM170A TNNT3 TPD52L2 UFL1 ULK3 WNT2B WNT3 ZBTB46
Angina 2.33 2 1 3.0 0.00 1.0e+00 FES RP11-463M16.4
Medication: Metformin 1.67 2 0 0.0 0.00 1.0e+00 CISD2 PMS2P5
Pack years adult smoking proportion 1.19 1 0 0.0 0.00 1.0e+00 PMS2P5
Impedance of leg (right) 2.33 38 23 69.7 -0.02 8.8e-01 ABCF3 ATG7 CEP41 CERS5 CTB-31O20.6 CTC-228N24.3 CTD-3032J10.3 CTSW DBN1 FES HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 MSRA MYO9B NEIL2 NELFCD NOC3L NT5C2 PMS2P5 PRKD3 RP11-463M16.4 RP4-758J18.10 SENP3 SLC35F6 SRR STAG3L1 SUOX SWAP70 TBC1D12 TMEM133 USP37 WDR66 WNT2B ZNF318 ZNF641
Leg fat-free mass (left) 1.88 25 14 42.4 0.12 5.6e-01 ABCF3 CENPW CTB-31O20.6 CTC-228N24.3 CTSW DBN1 DCAF16 FES HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 MSRA NEIL2 NT5C2 PDLIM4 PRELID1P1 SLC35F6 SRR STAG3L1 SUOX TDRD1 ULK3 WDR66
Trunk fat percentage 1.95 25 8 24.2 0.67 2.5e-04 AARS CDK10 CHP1 COX5A CTB-31O20.6 CTD-3032J10.3 CTSW HSD17B12 KAT8 KCNK3 KDM2B MRAS MYO9B NOC3L RNF34 RP11-810M2.2 RP5-1115A15.1 SENP3 SRR STAG3L1 TBC1D12 TEX15 TNFRSF25 WNT2B WNT3
Hand grip strength (right) 1.52 4 3 9.1 -0.95 5.5e-02 DCAF16 JARID2 PDLIM4 WNT2B
Townsend deprivation index at recruitment 1.24 1 0 0.0 0.00 1.0e+00 KLF16
Current tobacco smoking 1.36 1 0 0.0 0.00 1.0e+00 MSRA
Maternal smoking around birth 1.27 1 0 0.0 0.00 1.0e+00 C20orf160
Fed-up feelings 1.13 2 1 3.0 0.00 1.0e+00 SH2B3 TEX15
Relative age voice broke 1.07 1 0 0.0 0.00 1.0e+00 WNT3
Taking other prescription medications 1.87 5 1 3.0 1.00 1.4e-04 CHP1 CISD2 PMS2P5 SH2B3 ZNF318
Age when periods started (menarche) 1.65 7 4 12.1 -0.36 4.2e-01 CTB-31O20.6 CTSW HSD17B12 KLF16 PMS2P5 STAG3L1 SUOX
Heel bone mineral density (BMD) T-score, automated (left) 2.07 10 7 21.2 -0.21 5.7e-01 ACP2 BICC1 C6orf174 KREMEN1 LSMD1 MSRA NEIL2 RP5-1115A15.1 SIPA1 WNT2B
High blood pressure 13.72 145 129 390.9 1.00 6.0e-204 AARS ABCF3 AC006111.1 ACE ACP2 ADRB2 AGT AGTRAP AKR1B1 AQP5 ARID3B ATG7 ATP2B1 BICC1 C1GALT1 C20orf160 C3orf63 C4orf22 C6orf174 CCDC112 CD164L2 CDK10 CENPW CEP41 CERS5 CHP1 CISD2 CLCN6 COX5A CSK CTB-31O20.6 CTC-228N24.3 CTC-429P9.1 CTC-506B8.1 CTD-3032J10.3 CTSW CWF19L2 CYP11A1 DBN1 DCAF16 DRAXIN EFR3B ENPEP EXOC4 FBF1 FCF1P2 FES FLJ13197 GLTP GOPC GTF2B HOXB2 HRCT1 HSD17B12 INPP5A JARID2 KAT2B KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KIF2A KLF16 KREMEN1 LDB3 LFNG LIME1 LSMD1 MFN2 MGRN1 MOBP MPI MRAS MSRA MYO9B NCOA1 NDUFAF6 NEIL2 NELFCD NOC3L NPPA-AS1 NRBF2 NSUN6 NT5C2 OSGIN2 PDLIM4 PDXK PHIP PIGV PLCB1 PMS2P5 PRDM8 PRELID1P1 PRKD3 PTPN12 PVRIG RASIP1 RNF34 RP11-1055B8.4 RP11-463M16.4 RP11-538P18.2 RP11-588K22.2 RP11-810M2.2 RP4-635E18.7 RP4-758J18.10 RP5-1115A15.1 RPP25 SENP3 SH2B3 SIK2 SIPA1 SLC2A4 SLC35F6 SLC4A7 SNX16 SRR STAG3L1 STK32C SUOX SWAP70 TBC1D12 TBC1D19 TCEA2 TDRD1 TEX15 THEM6 TMEM133 TMEM170A TNFRSF25 TNNT3 TPD52L2 TSPY26P UBL3 UFL1 ULK3 USP37 VEGFB WDR66 WNT2B WNT3 YEATS4 ZBTB46 ZNF318 ZNF641
Hayfever, allergic rhinitis or eczema 1.96 5 5 15.2 0.34 5.8e-01 CHP1 PDLIM4 RP5-1115A15.1 SIK2 SUOX
Supplements: Glucosamine 1.76 2 1 3.0 0.00 1.0e+00 CSK NRBF2
Medication: Atenolol 5.15 4 2 6.1 0.98 1.5e-02 FES PRKD3 SH2B3 TMEM133
Medication: Levothyroxine sodium 1.81 3 2 6.1 0.00 1.0e+00 MSRA SH2B3 SUOX
Sitting height 1.40 20 14 42.4 -0.24 3.0e-01 C20orf160 CENPW CERS5 CHP1 DCAF16 GOPC GTF2B JARID2 KIAA1199 PDLIM4 PRELID1P1 RASIP1 RP11-463M16.4 RP11-538P18.2 SLC35F6 SLC4A7 TBC1D12 WDR66 WNT3 ZNF641
High blood pressure (mother) 5.17 11 3 9.1 0.97 4.0e-07 AGT C6orf174 CENPW CLCN6 FES NT5C2 PIGV SLC4A7 TMEM170A TNFRSF25 TNNT3
Body mass index (BMI) 2.27 28 15 45.5 0.66 1.3e-04 AARS CEP41 COX5A CTB-31O20.6 CTSW CYP11A1 GTF2B HSD17B12 KAT8 KCNK3 KDM2B KIAA1199 KLF16 MSRA NEIL2 NRBF2 NT5C2 PMS2P5 RP5-1115A15.1 RPP25 SRR STAG3L1 SUOX TDRD1 TEX15 TNFRSF25 ULK3 USP37
Impedance of leg (left) 2.37 37 26 78.8 -0.09 6.2e-01 AARS ABCF3 ATG7 CEP41 CERS5 CTB-31O20.6 CTC-228N24.3 CTD-3032J10.3 CTSW DBN1 FES HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 MSRA MYO9B NEIL2 NELFCD NOC3L NT5C2 PMS2P5 PRKD3 RP11-463M16.4 RP4-758J18.10 SLC35F6 SRR STAG3L1 SUOX SWAP70 TBC1D12 TMEM133 USP37 WNT2B ZNF318 ZNF641
Leg predicted mass (left) 1.87 25 13 39.4 0.15 4.7e-01 ABCF3 CENPW CTB-31O20.6 CTC-228N24.3 CTSW DBN1 DCAF16 HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 MSRA MYO9B NEIL2 NT5C2 PDLIM4 PRELID1P1 SLC35F6 SRR STAG3L1 SUOX TDRD1 ULK3 WDR66
Trunk fat mass 1.89 23 7 21.2 0.57 4.9e-03 AARS COX5A CTB-31O20.6 CTSW EFR3B HSD17B12 KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MRAS NT5C2 RP11-810M2.2 RP5-1115A15.1 RPP25 SRR STAG3L1 TDRD1 TEX15 TNFRSF25 WNT2B
Waist circumference 2.16 27 10 30.3 0.53 4.2e-03 AARS COX5A CSK CTB-31O20.6 CTSW CYP11A1 EFR3B EXOC4 HSD17B12 KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MPI NRBF2 PHIP RP11-810M2.2 RPP25 SRR STAG3L1 SUOX TDRD1 TEX15 TNFRSF25 ULK3
Number of incorrect matches in round 1.20 2 0 0.0 0.00 1.0e+00 JARID2 KAT8
Past tobacco smoking 1.27 3 0 0.0 0.00 1.0e+00 AQP5 SH2B3 SRR
Nervous feelings 1.25 4 1 3.0 -0.61 3.9e-01 KAT8 MSRA NEIL2 NT5C2
Frequency of tenseness / restlessness in last 2 weeks 1.00 1 0 0.0 0.00 1.0e+00 NT5C2
Hearing difficulty/problems with background noise 1.46 3 1 3.0 0.00 1.0e+00 CSK ULK3 ZNF318
Hair/balding pattern: Pattern 2 1.45 2 1 3.0 0.00 1.0e+00 C4orf22 PRDM8
Had menopause 1.01 1 0 0.0 0.00 1.0e+00 CHP1
Forced vital capacity (FVC) 1.67 11 4 12.1 -0.42 2.0e-01 ACP2 CENPW CTC-228N24.3 DCAF16 HOXB2 KAT8 NCOA1 RP11-538P18.2 WDR66 WNT2B WNT3
Heel bone mineral density (BMD) T-score, automated (right) 2.00 10 7 21.2 -0.07 8.5e-01 ACP2 C6orf174 DCAF16 KREMEN1 LSMD1 MSRA NEIL2 RP5-1115A15.1 SIPA1 WNT2B
Qualifications: None of the above 1.32 2 1 3.0 0.00 1.0e+00 PHIP SUOX
Mouth/teeth dental problems 1.46 2 0 0.0 0.00 1.0e+00 PMS2P5 RASIP1
Heart attack 2.02 1 1 3.0 0.00 1.0e+00 FES
Allergy 2.04 7 5 15.2 -0.02 9.7e-01 CHP1 FES LIME1 PDLIM4 RP5-1115A15.1 SIK2 SUOX
Diabetes (self-reported) 1.92 2 1 3.0 0.00 1.0e+00 PMS2P5 ZBTB46
Hayfever/allergic rhinitis (self-reported) 1.56 1 0 0.0 0.00 1.0e+00 SUOX
Medication: Ramipril 4.25 6 2 6.1 0.97 1.8e-03 CISD2 CSK CYP11A1 FES GOPC TMEM133
Medication: Simvastatin 3.45 6 1 3.0 0.92 8.4e-03 FES PIGV RASIP1 TMEM133 VEGFB YEATS4
Fluid intelligence score 1.11 1 1 3.0 0.00 1.0e+00 DCAF16
Illnesses of siblings 3.49 7 0 0.0 -0.97 3.2e-04 FES FLJ13197 KAT8 NRBF2 PRELID1P1 SH2B3 TMEM133
Neuroticism score 1.09 4 3 9.1 -0.99 1.1e-02 MSRA NEIL2 RP5-1115A15.1 WNT3
Weight 1.90 28 14 42.4 0.35 6.8e-02 AARS CTB-31O20.6 CTSW DCAF16 EFR3B EXOC4 FLJ13197 HSD17B12 KAT8 KB-1107E3.1 KCNK3 KIAA1199 KLF16 MRAS MSRA NEIL2 NT5C2 PDLIM4 RP11-810M2.2 RPP25 SH2B3 SRR STAG3L1 SUOX TDRD1 ULK3 WDR66 WNT2B
Impedance of arm (right) 1.95 31 13 39.4 -0.30 9.8e-02 CEP41 CERS5 CISD2 CTB-31O20.6 CTD-3032J10.3 CTSW CYP11A1 HSD17B12 KAT8 KIAA1199 KLF16 KREMEN1 LIME1 MSRA MYO9B NEIL2 NOC3L NRBF2 RP11-463M16.4 SENP3 SLC4A7 SNX16 STAG3L1 SUOX SWAP70 TBC1D12 TNNT3 TSPY26P ULK3 WNT2B ZNF641
Arm fat percentage (right) 2.07 25 12 36.4 0.78 4.4e-06 AARS CHP1 COX5A CTB-31O20.6 CTSW DCAF16 FBF1 HSD17B12 KAT8 KCNK3 KDM2B KLF16 MSRA NT5C2 PMS2P5 RNF34 RP11-810M2.2 RP5-1115A15.1 SENP3 SLC2A4 SRR STAG3L1 TDRD1 TEX15 TNFRSF25
Trunk fat-free mass 1.82 28 16 48.5 -0.11 5.7e-01 CCDC112 CENPW CTD-3032J10.3 DBN1 DCAF16 EFR3B HSD17B12 JARID2 KAT8 KCNK3 KIAA1199 KLF16 LIME1 MYO9B NCOA1 NT5C2 PDLIM4 PRELID1P1 RASIP1 SENP3 SH2B3 SLC35F6 SLC4A7 SUOX TBC1D12 TMEM133 ULK3 WDR66
Hip circumference 1.99 25 9 27.3 0.22 2.9e-01 AARS CCDC112 CLCN6 CTB-31O20.6 DCAF16 FBF1 HSD17B12 KAT8 KB-1107E3.1 KCNK3 KIAA1199 KLF16 MRAS MSRA NPPA-AS1 NT5C2 PHIP PMS2P5 RASIP1 RP11-810M2.2 SH2B3 SRR STAG3L1 VEGFB WDR66
Alcohol intake versus 10 years previously 1.18 1 0 0.0 0.00 1.0e+00 RASIP1
Father's age at death 2.19 2 2 6.1 0.00 1.0e+00 FES SH2B3
Worrier / anxious feelings 1.51 4 1 3.0 -0.59 4.1e-01 KAT8 MSRA NEIL2 NT5C2
Frequency of tiredness / lethargy in last 2 weeks 1.16 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Hair/balding pattern: Pattern 3 1.56 3 2 6.1 0.00 1.0e+00 C4orf22 PRDM8 WNT3
Forced expiratory volume in 1-second (FEV1) 1.76 13 3 9.1 -0.23 4.5e-01 DCAF16 GOPC HOXB2 KAT8 MSRA NCOA1 NRBF2 PDLIM4 RP11-538P18.2 SUOX TMEM133 TSPY26P WNT3
Qualifications: A levels/AS levels or equivalent 1.26 3 0 0.0 0.00 1.0e+00 DCAF16 STAG3L1 SUOX
Mouth/teeth dental problems: Dentures 1.19 2 1 3.0 0.00 1.0e+00 RASIP1 RP11-1055B8.4
Asthma 1.76 4 4 12.1 -0.15 8.5e-01 PDLIM4 RP5-1115A15.1 SIK2 SUOX
Medication: Cholesterol lowering 3.60 9 3 9.1 0.98 2.6e-06 CHP1 FES PIGV PVRIG RASIP1 TMEM133 TNFRSF25 YEATS4 ZNF641
Depression (self-reported) 1.09 1 1 3.0 0.00 1.0e+00 RP5-1115A15.1
Illnesses of mother 3.35 2 1 3.0 0.00 1.0e+00 AGT FES
Forced expiratory volume in 1-second (FEV1), Best measure 1.79 11 6 18.2 -0.24 4.7e-01 AQP5 DCAF16 KAT8 MSRA NCOA1 NRBF2 PDLIM4 RP11-538P18.2 SUOX TMEM133 WNT3
Pulse wave Arterial Stiffness index 1.78 2 0 0.0 0.00 1.0e+00 DRAXIN VEGFB
Impedance of arm (left) 1.93 28 14 42.4 -0.19 3.4e-01 CERS5 CISD2 CTD-3032J10.3 CTSW CYP11A1 HSD17B12 KAT8 KIAA1199 KREMEN1 LIME1 MSRA MYO9B NEIL2 NOC3L NRBF2 PRKD3 RP11-463M16.4 SENP3 SH2B3 SLC4A7 STAG3L1 SUOX TBC1D12 TNNT3 TSPY26P ULK3 WNT2B ZNF641
Arm fat mass (right) 2.08 26 10 30.3 0.69 8.6e-05 AARS COX5A CTB-31O20.6 CTC-506B8.1 CTSW EFR3B HSD17B12 KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MSRA NT5C2 PMS2P5 RP11-810M2.2 RP5-1115A15.1 RPP25 SRR STAG3L1 SUOX TDRD1 TEX15 TNFRSF25 ULK3
Trunk predicted mass 1.83 27 15 45.5 -0.09 6.6e-01 CCDC112 CENPW CTD-3032J10.3 DBN1 DCAF16 EFR3B HSD17B12 JARID2 KAT8 KCNK3 KIAA1199 KLF16 LIME1 MYO9B NCOA1 NT5C2 PDLIM4 PRELID1P1 RASIP1 SENP3 SH2B3 SLC35F6 SLC4A7 SUOX TBC1D12 ULK3 WDR66
Standing height 1.62 33 18 54.5 -0.42 1.5e-02 AC006111.1 ACP2 BICC1 CENPW CERS5 CHP1 DBN1 DCAF16 EFR3B GOPC GTF2B HOXB2 MGRN1 MSRA NCOA1 PDLIM4 PIGV PRELID1P1 PTPN12 RASIP1 RP11-1055B8.4 RP11-463M16.4 RP11-538P18.2 RP11-810M2.2 RP4-635E18.7 RP5-1115A15.1 SH2B3 SLC35F6 TMEM170A USP37 WDR66 WNT2B ZNF318
Breastfed as a baby 0.99 1 0 0.0 0.00 1.0e+00 RP4-758J18.10
Tense / 'highly strung' 1.10 3 0 0.0 0.00 1.0e+00 KAT8 NT5C2 RP5-1115A15.1
Seen doctor (GP) for nerves, anxiety, tension or depression 1.24 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Hair/balding pattern: Pattern 4 2.04 9 5 15.2 0.34 3.7e-01 C4orf22 CENPW CERS5 KAT2B PRDM8 PRELID1P1 RP5-1115A15.1 SRR WNT3
Birth weight of first child 2.97 14 5 15.2 -0.98 1.7e-11 AGTRAP CLCN6 COX5A CSK CTC-228N24.3 DCAF16 FES GTF2B NPPA-AS1 RPP25 SH2B3 STAG3L1 TBC1D12 TMEM170A
Peak expiratory flow (PEF) 1.55 6 2 6.1 -0.74 9.5e-02 C1GALT1 DCAF16 MSRA RASIP1 TMEM170A WNT3
Pulse wave reflection index 1.41 1 0 0.0 0.00 1.0e+00 INPP5A
Medication: Paracetamol 1.47 1 0 0.0 0.00 1.0e+00 UFL1
Headache pain in last month 1.59 3 1 3.0 0.00 1.0e+00 TMEM170A UFL1 WNT3
Medication for cholesterol, blood pressure or diabetes 7.27 35 13 39.4 -0.99 5.9e-27 AARS ACE ATP2B1 C1GALT1 C4orf22 CHP1 CISD2 CLCN6 CSK CTC-228N24.3 CTD-3032J10.3 CTSW DRAXIN FCF1P2 FES FLJ13197 JARID2 KIAA1199 LFNG OSGIN2 PDXK PLCB1 PVRIG RASIP1 RP11-588K22.2 SH2B3 SIK2 SLC4A7 TMEM133 TNFRSF25 TSPY26P WNT2B YEATS4 ZBTB46 ZNF641
Glaucoma (self-reported) 1.28 1 0 0.0 0.00 1.0e+00 BICC1
Gout (self-reported) 1.57 2 0 0.0 0.00 1.0e+00 SH2B3 SIPA1
Hypothyroidism/myxoedema (self-reported) 1.84 4 2 6.1 0.02 9.8e-01 MSRA RP5-1115A15.1 SH2B3 SUOX
Medication: Amlodipine 6.51 19 11 33.3 0.97 3.1e-13 C6orf174 CD164L2 CLCN6 FES FLJ13197 KCNK3 KDM2B KIAA1199 NPPA-AS1 OSGIN2 RNF34 RP4-635E18.7 SENP3 SLC35F6 SLC4A7 TMEM133 TNNT3 WNT2B ZNF318
Birth weight 2.34 9 6 18.2 -0.67 4.7e-02 DBN1 DCAF16 FES RASIP1 SH2B3 SIK2 SLC2A4 SRR TNNT3
High blood pressure (siblings) 4.60 9 4 12.1 0.95 6.1e-05 ACP2 CLCN6 FES KAT8 NRBF2 PRELID1P1 SH2B3 TMEM133 TNNT3
Forced vital capacity (FVC), Best measure 1.64 10 5 15.2 -0.41 2.4e-01 ACP2 CENPW CTC-228N24.3 DBN1 DCAF16 HOXB2 KAT8 NCOA1 RP11-538P18.2 WNT3
Body fat percentage 2.10 27 9 27.3 0.71 3.6e-05 AARS CHP1 COX5A CTB-31O20.6 CTSW DCAF16 HSD17B12 KAT8 KCNK3 KDM2B MRAS MSRA MYO9B NOC3L PMS2P5 RNF34 RP11-810M2.2 RP5-1115A15.1 RPP25 SENP3 SRR STAG3L1 TBC1D12 TEX15 TNFRSF25 WNT2B WNT3
Leg fat percentage (right) 2.30 24 12 36.4 0.77 1.1e-05 AARS CHP1 COX5A CTB-31O20.6 CTC-228N24.3 CTSW DCAF16 GTF2B HSD17B12 KAT8 KCNK3 KDM2B MOBP MSRA NOC3L RP11-810M2.2 RP5-1115A15.1 RPP25 SLC2A4 STAG3L1 TBC1D12 TEX15 TNFRSF25 WNT2B
Arm fat-free mass (right) 1.83 25 12 36.4 0.01 9.6e-01 CENPW CTSW DBN1 DCAF16 EFR3B EXOC4 HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 LIME1 MYO9B NEIL2 NT5C2 PDLIM4 PRELID1P1 RASIP1 SENP3 SH2B3 SLC35F6 STAG3L1 SUOX ULK3 WDR66
Comparative body size at age 10 1.78 12 5 15.2 0.06 8.6e-01 AQP5 ATG7 CERS5 EFR3B FCF1P2 KAT8 MSRA RASIP1 SIPA1 SRR WNT2B ZNF318
Worry too long after embarrassment 1.12 1 0 0.0 0.00 1.0e+00 MSRA
Wheeze or whistling in the chest in last year 1.56 1 1 3.0 0.00 1.0e+00 SIK2
Age at first live birth 1.37 1 0 0.0 0.00 1.0e+00 DCAF16
Qualifications: College or University degree 1.18 7 4 12.1 -0.74 5.9e-02 DCAF16 GTF2B STAG3L1 SUOX TEX15 TNFRSF25 WNT3
Medication for pain relief, constipation, heartburn 1.84 5 1 3.0 -0.99 5.0e-04 C20orf160 KIAA1199 PRDM8 UFL1 YEATS4
Neck or shoulder pain in last month 1.41 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Medication: Blood pressure 9.58 58 25 75.8 0.99 5.1e-52 ACE ACP2 ATP2B1 BICC1 C1GALT1 C20orf160 C4orf22 CCDC112 CEP41 CISD2 CLCN6 CSK CTC-228N24.3 CTSW CWF19L2 CYP11A1 DCAF16 DRAXIN EFR3B FCF1P2 FES FLJ13197 HOXB2 JARID2 KDM2B KIAA1199 KLF16 LDB3 LFNG MOBP MSRA NELFCD NOC3L NPPA-AS1 OSGIN2 PDXK PLCB1 PRDM8 PRELID1P1 PVRIG RNF34 RP11-463M16.4 RP11-810M2.2 RP4-635E18.7 SENP3 SH2B3 SIK2 SIPA1 SLC2A4 SLC4A7 STAG3L1 TMEM133 TNNT3 TSPY26P ULK3 WDR66 WNT2B ZBTB46
Angina (self-reported) 2.31 1 1 3.0 0.00 1.0e+00 FES
Migraine (self-reported) 1.42 1 1 3.0 0.00 1.0e+00 UFL1
Medication: Allopurinol 1.71 3 1 3.0 0.00 1.0e+00 LSMD1 SH2B3 WDR66
Medication: Seretide 50 evohaler 1.20 1 0 0.0 0.00 1.0e+00 PDLIM4
Mean time to correctly identify matches 1.16 2 1 3.0 0.00 1.0e+00 RP11-810M2.2 SH2B3
Whole body fat mass 1.97 24 12 36.4 0.61 1.7e-03 AARS COX5A CTB-31O20.6 CTSW HSD17B12 KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MRAS MSRA NT5C2 PMS2P5 RP11-810M2.2 RP5-1115A15.1 RPP25 SRR STAG3L1 TDRD1 TEX15 TNFRSF25 WNT2B
Leg fat mass (right) 2.10 23 9 27.3 0.73 6.8e-05 AARS CTB-31O20.6 CTSW HSD17B12 KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MOBP MRAS MSRA PMS2P5 RP11-810M2.2 RP5-1115A15.1 RPP25 STAG3L1 TEX15 TNFRSF25 TSPY26P ULK3 WNT2B
Arm predicted mass (right) 1.84 24 12 36.4 0.07 7.6e-01 CENPW DBN1 DCAF16 EFR3B HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 LIME1 MYO9B NEIL2 PDLIM4 PRELID1P1 RASIP1 SENP3 SH2B3 SLC35F6 SLC4A7 STAG3L1 SUOX TSPY26P ULK3 WDR66
Pulse rate, automated reading 1.21 5 1 3.0 -0.80 1.0e-01 ACP2 C4orf22 PVRIG SIK2 SUOX
Alcohol intake frequency. 1.50 5 3 9.1 0.57 3.2e-01 KAT8 PMS2P5 RASIP1 SUOX TEX15
Comparative height size at age 10 1.61 16 10 30.3 -0.34 1.9e-01 CENPW DBN1 DCAF16 GTF2B KIAA1199 NCOA1 PDLIM4 PIGV PRELID1P1 RASIP1 RP11-810M2.2 RP4-635E18.7 RP5-1115A15.1 SH2B3 WDR66 WNT2B
Number of full sisters 1.49 1 0 0.0 0.00 1.0e+00 NRBF2
Suffer from 'nerves' 1.07 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Overall health rating 2.00 9 5 15.2 0.98 1.8e-06 C1GALT1 CTSW KAT8 MSRA PMS2P5 SUOX TEX15 TNFRSF25 TSPY26P
Chest pain or discomfort 1.47 1 0 0.0 0.00 1.0e+00 KB-1107E3.1
Medication: Aspirin 3.44 5 1 3.0 0.97 5.8e-03 FES GOPC RP11-463M16.4 SIK2 VEGFB
Gastro-oesophageal reflux (gord) / gastric reflux (Self-reported) 1.40 1 0 0.0 0.00 1.0e+00 KDM2B
Illnesses of father: Heart disease 1.71 1 1 3.0 0.00 1.0e+00 FES
Smoking status: Previous 1.19 1 0 0.0 0.00 1.0e+00 SH2B3
Forced expiratory volume in 1-second (FEV1), predicted 1.40 3 2 6.1 0.00 1.0e+00 DCAF16 MGRN1 PDLIM4
Whole body fat-free mass 1.87 26 17 51.5 -0.07 7.4e-01 CCDC112 CENPW CTC-228N24.3 DBN1 DCAF16 EFR3B HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 MYO9B NEIL2 NT5C2 PDLIM4 PRELID1P1 RASIP1 SENP3 SH2B3 SLC35F6 SLC4A7 STAG3L1 SUOX TBC1D12 ULK3 WDR66
Leg fat-free mass (right) 1.91 28 16 48.5 -0.05 8.1e-01 ABCF3 CENPW CTC-228N24.3 CTSW DBN1 DCAF16 FES HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 MSRA MYO9B NEIL2 NT5C2 PDLIM4 PRELID1P1 SH2B3 SLC35F6 SRR STAG3L1 SUOX TBC1D12 TDRD1 TMEM133 ULK3 WDR66
Arm fat percentage (left) 2.09 24 14 42.4 0.71 1.1e-04 AARS CHP1 COX5A CTB-31O20.6 CTSW DCAF16 FBF1 HSD17B12 KAT8 KCNK3 KDM2B KLF16 MSRA NT5C2 PMS2P5 RNF34 RP11-810M2.2 RP5-1115A15.1 RPP25 SENP3 SRR STAG3L1 TEX15 TNFRSF25
Average weekly red wine intake 1.27 1 0 0.0 0.00 1.0e+00 MPI
Mood swings 1.16 3 0 0.0 0.00 1.0e+00 ACP2 OSGIN2 WNT3
Loneliness, isolation 1.28 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Long-standing illness, disability or infirmity 1.54 2 0 0.0 0.00 1.0e+00 CHP1 PMS2P5
Ever had bowel cancer screening 1.05 1 0 0.0 0.00 1.0e+00 SIK2
Diabetes diagnosed by doctor 2.16 5 2 6.1 0.98 4.6e-03 ACE CTSW MRAS PMS2P5 ZBTB46
Mouth/teeth dental problems: Mouth ulcers 1.21 2 0 0.0 0.00 1.0e+00 OSGIN2 WNT3
Medication for cholesterol 6.48 26 7 21.2 -0.97 3.9e-17 ACE AGT ATG7 C4orf22 C6orf174 CDK10 CENPW CISD2 CWF19L2 FES JARID2 KAT8 KIAA1199 LIME1 MGRN1 PIGV PLCB1 PRELID1P1 PRKD3 RASIP1 SH2B3 TMEM133 TNNT3 VEGFB WNT2B ZBTB46
Back pain experienced in last month 1.43 1 0 0.0 0.00 1.0e+00 WDR66
Mineral and other dietary supplements 1.07 1 0 0.0 0.00 1.0e+00 NRBF2
Breast cancer (self-reported) 1.33 1 1 3.0 0.00 1.0e+00 SLC4A7
Asthma (self-reported) 1.70 5 4 12.1 -0.25 6.8e-01 FBF1 PDLIM4 RP5-1115A15.1 SIK2 SUOX
Osteoarthritis (self-reported) 1.61 2 0 0.0 0.00 1.0e+00 COX5A RPP25
Medication: Aspirin 3.54 4 1 3.0 0.98 1.8e-02 FES RP11-463M16.4 SIK2 VEGFB
Illnesses of father: None of the above (group 1) 2.22 2 1 3.0 0.00 1.0e+00 FES SH2B3
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.61 5 3 9.1 -0.22 7.2e-01 KAT8 NRBF2 RP11-538P18.2 TMEM170A WNT3
Whole body water mass 1.87 28 17 51.5 -0.03 8.9e-01 CCDC112 CENPW CTC-228N24.3 DBN1 DCAF16 EFR3B HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 LIME1 MSRA MYO9B NEIL2 NT5C2 PDLIM4 PRELID1P1 SENP3 SH2B3 SLC35F6 SLC4A7 STAG3L1 SUOX TBC1D12 TMEM133 ULK3 WDR66
Leg predicted mass (right) 1.91 28 16 48.5 -0.05 8.1e-01 ABCF3 CENPW CTC-228N24.3 CTSW DBN1 DCAF16 FES HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 MSRA MYO9B NEIL2 NT5C2 PDLIM4 PRELID1P1 SH2B3 SLC35F6 SRR STAG3L1 SUOX TBC1D12 TDRD1 TMEM133 ULK3 WDR66
Arm fat mass (left) 2.04 25 11 33.3 0.63 7.9e-04 AARS COX5A CTB-31O20.6 CTC-506B8.1 CTSW EFR3B FBF1 HSD17B12 KAT8 KCNK3 KDM2B KIAA1199 KLF16 MRAS MSRA NT5C2 PMS2P5 RP11-810M2.2 RP5-1115A15.1 RPP25 SRR STAG3L1 TDRD1 TEX15 TNFRSF25
Number of self-reported non-cancer illnesses 4.21 10 3 9.1 0.98 3.0e-07 CISD2 KDM2B LSMD1 MYO9B PDLIM4 PMS2P5 RASIP1 SH2B3 SNX16 ZNF318
Miserableness 1.08 3 0 0.0 0.00 1.0e+00 ACP2 RP5-1115A15.1 WNT3
Guilty feelings 0.92 1 0 0.0 0.00 1.0e+00 NEIL2
Mother's age at death 1.95 1 0 0.0 0.00 1.0e+00 CLCN6
Financial situation satisfaction 1.06 1 0 0.0 0.00 1.0e+00 ULK3
Eye problems/disorders: Glaucoma 1.30 1 0 0.0 0.00 1.0e+00 TEX15
Medication: Blood pressure 10.40 79 34 103.0 0.99 6.4e-63 ACE ACP2 ADRB2 AGT AKR1B1 AQP5 ARID3B ATG7 ATP2B1 C1GALT1 C4orf22 C6orf174 CDK10 CENPW CERS5 CHP1 CISD2 CLCN6 COX5A CSK CTD-3032J10.3 CTSW CWF19L2 CYP11A1 FCF1P2 FES GTF2B HRCT1 KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 LFNG LIME1 LSMD1 MGRN1 MPI MRAS MSRA MYO9B NCOA1 NEIL2 NRBF2 NSUN6 NT5C2 PDLIM4 PDXK PIGV PLCB1 PRELID1P1 PRKD3 PTPN12 RASIP1 RNF34 RP11-1055B8.4 RP11-588K22.2 RP11-810M2.2 RP4-635E18.7 RPP25 SENP3 SH2B3 SIK2 SIPA1 SLC35F6 SLC4A7 TBC1D19 TDRD1 TEX15 TMEM133 TNNT3 TPD52L2 UBL3 ULK3 VEGFB WNT2B WNT3 ZBTB46 ZNF318
High cholesterol (Self-reported) 2.97 7 5 15.2 0.91 4.0e-03 CWF19L2 DCAF16 FBF1 PIGV RASIP1 TMEM133 VEGFB
Medication: Bendroflumethiazide 7.05 29 7 21.2 0.97 5.2e-19 ABCF3 ACP2 ATP2B1 C6orf174 CCDC112 CD164L2 CDK10 CSK FES KAT8 KIAA1199 MGRN1 MYO9B NEIL2 NRBF2 PDLIM4 PIGV PLCB1 PRELID1P1 RP11-463M16.4 SENP3 SH2B3 SLC35F6 SLC4A7 TEX15 TMEM133 TNNT3 USP37 WNT2B
Medication: Paracetamol 1.47 1 0 0.0 0.00 1.0e+00 UFL1
Medication: Lisinopril 4.12 5 0 0.0 0.97 4.8e-03 ACP2 CSK FCF1P2 NRBF2 TMEM133
Medication: Atorvastatin 1.71 1 0 0.0 0.00 1.0e+00 RASIP1
Illnesses of father: High blood pressure 3.84 6 1 3.0 0.98 4.7e-04 ACE ACP2 C4orf22 FES NCOA1 PLCB1
Ever smoked 1.26 2 0 0.0 0.00 1.0e+00 SH2B3 SRR
Basal metabolic rate 1.85 24 15 45.5 0.10 6.3e-01 CCDC112 CENPW CTC-228N24.3 CTSW DBN1 DCAF16 EFR3B HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 MSRA NEIL2 NT5C2 PDLIM4 PRELID1P1 SH2B3 SLC35F6 STAG3L1 SUOX TDRD1 ULK3 WDR66
Leg fat percentage (left) 2.32 25 10 30.3 0.77 7.2e-06 AARS CHP1 COX5A CTB-31O20.6 CTC-228N24.3 CTSW DCAF16 GTF2B HSD17B12 KAT8 KCNK3 KDM2B MOBP MSRA NOC3L PMS2P5 RP11-810M2.2 RP5-1115A15.1 RPP25 SLC2A4 STAG3L1 TBC1D12 TEX15 TNFRSF25 WNT2B
Arm fat-free mass (left) 1.82 26 12 36.4 0.17 3.9e-01 CENPW CTSW DCAF16 EFR3B HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 LIME1 MSRA NEIL2 NT5C2 PDLIM4 PRELID1P1 RASIP1 RP11-810M2.2 SENP3 SH2B3 SLC35F6 SLC4A7 STAG3L1 SUOX TSPY26P ULK3 WDR66
Average weekly beer plus cider intake 1.44 2 0 0.0 0.00 1.0e+00 AQP5 CCDC112
Irritability 1.09 2 2 6.1 0.00 1.0e+00 MSRA NEIL2
Risk taking 1.19 1 0 0.0 0.00 1.0e+00 KCNK3
Diastolic blood pressure, automated reading 7.86 72 44 133.3 0.97 9.0e-48 AC006111.1 ACP2 AGT AGTRAP AQP5 ATP2B1 C1GALT1 C20orf160 C4orf22 C6orf174 CCDC112 CENPW CEP41 CERS5 CHP1 CLCN6 COX5A CSK CTB-31O20.6 CTD-3032J10.3 CTSW CYP11A1 DCAF16 DRAXIN ENPEP FCF1P2 FES GLTP HRCT1 KAT8 KIAA1199 KIF2A LFNG LIME1 LSMD1 MFN2 MPI MSRA MYO9B NCOA1 NDUFAF6 NEIL2 NELFCD NOC3L NPPA-AS1 NRBF2 NSUN6 NT5C2 PDLIM4 PHIP PIGV PMS2P5 PRELID1P1 PVRIG RP11-463M16.4 RP11-538P18.2 RP5-1115A15.1 RPP25 SENP3 SH2B3 SIPA1 SLC2A4 SRR STAG3L1 SWAP70 TCEA2 THEM6 TMEM133 TNNT3 TSPY26P ULK3 WNT2B
Vascular/heart problems diagnosed by doctor 13.11 143 108 327.3 -1.00 4.3e-161 AARS ABCF3 AC006111.1 ACE ACP2 ADRB2 AGT AGTRAP AKR1B1 AQP5 ARID3B ATG7 ATP2B1 BICC1 C1GALT1 C20orf160 C3orf63 C4orf22 C6orf174 CCDC112 CD164L2 CDK10 CENPW CEP41 CERS5 CHP1 CISD2 CLCN6 COX5A CSK CTB-31O20.6 CTC-228N24.3 CTC-429P9.1 CTD-3032J10.3 CTSW CWF19L2 CYP11A1 DCAF16 DRAXIN EFR3B ENPEP EXOC4 FBF1 FCF1P2 FES FLJ13197 GLTP GOPC GTF2B HOXB2 HRCT1 HSD17B12 INPP5A JARID2 KAT2B KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KIF2A KLF16 KREMEN1 LDB3 LFNG LIME1 LSMD1 MFN2 MGRN1 MOBP MPI MRAS MSRA MYO9B NCOA1 NDUFAF6 NEIL2 NELFCD NOC3L NPPA-AS1 NRBF2 NSUN6 NT5C2 OSGIN2 PDLIM4 PDXK PHIP PIGV PLCB1 PMS2P5 PRDM8 PRELID1P1 PRKD3 PTPN12 PVRIG RASIP1 RNF34 RP11-1055B8.4 RP11-463M16.4 RP11-538P18.2 RP11-588K22.2 RP11-810M2.2 RP4-635E18.7 RP4-758J18.10 RP5-1115A15.1 RPP25 SENP3 SH2B3 SIK2 SIPA1 SLC2A4 SLC35F6 SLC4A7 SNX16 SRR STAG3L1 STK32C SUOX SWAP70 TBC1D12 TBC1D19 TCEA2 TDRD1 TEX15 THEM6 TMEM133 TMEM170A TNFRSF25 TNNT3 TPD52L2 TSPY26P UBL3 UFL1 ULK3 USP37 VEGFB WDR66 WNT2B WNT3 YEATS4 ZBTB46 ZNF318 ZNF641
Cholesterol lowering medication 2.61 6 2 6.1 0.99 1.1e-04 DCAF16 KAT8 PIGV RASIP1 RNF34 VEGFB
Pain experienced in last month 1.40 3 0 0.0 0.00 1.0e+00 KAT8 SUOX UFL1
Basal cell carcinoma (self-reported) 1.16 1 1 3.0 0.00 1.0e+00 CDK10
Heart attack/myocardial infarction (self-reported) 2.03 2 1 3.0 0.00 1.0e+00 FES SH2B3
Heart disease (siblings) 1.76 2 0 0.0 0.00 1.0e+00 FES PVRIG
Pack years of smoking 1.18 1 0 0.0 0.00 1.0e+00 PMS2P5
Impedance of whole body 2.17 39 23 69.7 -0.20 2.2e-01 AARS ABCF3 ATG7 CENPW CEP41 CERS5 CISD2 CTB-31O20.6 CTC-228N24.3 CTD-3032J10.3 CTSW CYP11A1 DBN1 HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 LIME1 MSRA MYO9B NEIL2 NOC3L NT5C2 PMS2P5 PRKD3 RP11-463M16.4 RP4-758J18.10 SENP3 SLC4A7 SRR STAG3L1 SUOX SWAP70 TBC1D12 ULK3 USP37 WNT2B ZNF641
Leg fat mass (left) 2.10 23 12 36.4 0.69 2.6e-04 AARS COX5A CTB-31O20.6 CTSW HSD17B12 KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MSRA PMS2P5 RP11-810M2.2 RP5-1115A15.1 RPP25 STAG3L1 TDRD1 TEX15 TNFRSF25 TSPY26P ULK3 WNT2B
Arm predicted mass (left) 1.85 26 11 33.3 0.13 5.2e-01 CENPW CTSW DBN1 DCAF16 EFR3B HSD17B12 KAT8 KCNK3 KIAA1199 KLF16 LIME1 MSRA NCOA1 NEIL2 NT5C2 PDLIM4 PRELID1P1 RASIP1 SENP3 SH2B3 SLC35F6 SLC4A7 STAG3L1 SUOX ULK3 WDR66

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 37 1.060 2.94
GTEx Adipose Visceral Omentum 19 0.933 2.96
GTEx Adrenal Gland 16 1.098 2.88
GTEx Artery Aorta 41 1.377 3.12
GTEx Artery Coronary 10 0.845 2.91
GTEx Artery Tibial 44 1.170 3.03
GTEx Brain Caudate basal ganglia 7 0.761 2.85
GTEx Brain Cerebellar Hemisphere 16 1.075 2.89
GTEx Brain Cerebellum 21 1.060 3.03
GTEx Brain Cortex 9 0.870 3.06
GTEx Brain Frontal Cortex BA9 10 1.082 3.02
GTEx Brain Hippocampus 2 0.382 2.77
GTEx Brain Hypothalamus 3 0.508 2.66
GTEx Brain Nucleus accumbens basal ganglia 5 0.578 2.93
GTEx Brain Putamen basal ganglia 4 0.641 2.70
GTEx Breast Mammary Tissue 21 1.064 2.89
GTEx Breast Mammary Tissue (Male) 15 1.257 2.86
GTEx Breast Mammary Tissue (Female) 17 1.034 2.86
GTEx Cells EBV-transformed lymphocytes 8 0.562 2.82
GTEx Cells Transformed fibroblasts 36 0.857 2.83
GTEx Colon Sigmoid 17 1.163 2.93
GTEx Colon Transverse 20 0.969 2.90
GTEx Esophagus Gastroesophageal Junction 16 1.107 3.00
GTEx Esophagus Mucosa 33 0.994 2.89
GTEx Esophagus Muscularis 36 1.114 2.90
GTEx Heart Atrial Appendage 14 0.887 2.85
GTEx Heart Left Ventricle 19 1.242 2.94
GTEx Liver 6 0.837 2.61
GTEx Lung 27 0.940 2.96
GTEx Muscle Skeletal 24 0.830 2.92
GTEx Nerve Tibial 36 0.833 2.78
GTEx Ovary 13 1.432 3.26
GTEx Pancreas 16 0.980 2.94
GTEx Pituitary 12 1.076 2.88
GTEx Prostate 15 1.796 3.16
GTEx Skin Not Sun Exposed Suprapubic 28 1.139 2.99
GTEx Skin Sun Exposed Lower leg 39 1.071 2.93
GTEx Small Intestine Terminal Ileum 3 0.651 2.97
GTEx Spleen 11 0.780 2.83
GTEx Stomach 21 1.444 3.14
GTEx Testis 32 1.014 2.91
GTEx Thyroid 43 1.075 2.89
GTEx Uterus 6 1.058 2.82
GTEx Vagina 5 0.787 2.99
GTEx Whole Blood 16 0.803 2.79
METSIM Adipose 25 0.542 2.55
NTR Blood 17 0.708 2.71
ROSMAP Brain Pre-frontal Cortex 56 1.275 3.00
YFS Blood 29 0.628 2.57
CommonMind Brain Pre-frontal Cortex 46 0.856 2.68
TCGA Breast Tumor 10 1.304 3.04
TCGA Breast Normal 26 0.618 2.53
TCGA Ovarian Tumor 13 0.445 2.41
TCGA Prostate Tumor 28 0.809 2.66